U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS
PEPFAR, the campaign to end H.I.V. globally, would morph into [...]
A Pill for Sleep Apnea Could Be on the Horizon
Experts say that if the new drug gets approved, it [...]
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The U.K.-based drugmaker plans to invest $50 billion in the [...]
First Pill for Postpartum Depression Shows Varied Real-World Results
Some women’s symptoms improved quickly after taking the pill, but [...]
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy
An agency-sponsored forum included critics of psychiatry who believe the [...]
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys
The regulator had asked Sarepta Therapeutics to halt all shipments [...]
Heath Insurers Are Denying More Drug Claims, Data Shows
Offering a rare glimpse inside the hidden world of rejected [...]
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Says
The Trump administration’s proposed cuts to medical research and health [...]
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, said too many women [...]
South African AIDS Activist Pushes for H.I.V. Treatment Access After U.S.-Aid Cuts
Zackie Achmat, once at the center of South Africa’s push [...]